Hormones · Critical Care Injectable
FARAHYD-250
Hydroxyprogesterone caproate 250 Mg / 2ml
Manufactured at WHO-GMP certified facility by BIOFRIL HEALTHCARE. Available for hospital tender supply, ICU pharmacy, and PCD franchise distribution across India.
Product Specifications
FARAHYD-250 at a Glance
| Brand Name | FARAHYD-250 |
|---|---|
| Composition | Hydroxyprogesterone caproate 250 Mg / 2ml |
| Therapeutic Category | Hormones |
| Division | Critical Care Injectable |
| Pack / Presentation | AMPOULE 1’S |
| Storage | Store below 25°C. Protect from light. |
| Manufacturer | BIOFRIL HEALTHCARE Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Schedule H — Sold on prescription of a Registered Medical Practitioner only |
Clinical Use
Indications & Clinical Applications
FARAHYD-250 (Hydroxyprogesterone caproate 250 Mg / 2ml) is indicated for the treatment of conditions in which Hydroxyprogesterone caproate 250 Mg / 2ml therapy is clinically appropriate. For complete prescribing information please refer to the official product insert.
Submit Enquiry for FARAHYD-250
PCD franchise · Hospital tender supply · Bulk procurement